HIV infection 200 mg PO q12hNo renal dose adjustment


Safety and efficacy in pediatric patients <6 years of age or <16 kg of BW have not been established

HIV infection

  • BW: 16-20 kg: 100 mg PO q12h

  • BW: 20-25 kg: 125 mg PO q12h

  • BW: 25-30 kg: 150 mg PO q12h

  • BW: >30 kg: 200 mg PO q12hNo renal dose adjustment

Mild or moderate hepatic impairment No dose adjustment

Severe hepatic impairment No data

General Information

HIV infection, Treatment-experienced patients

Monitor viral load prior to initiation or modification of treatment.

Monitor CD4 cell counts prior to initiation or with modification of ARV treatment and every 3-6 months; thereafter during at least the first 2 years of treatment.

Monitor hepatitis B screening.

Perform hepatitis C antibody testing prior to initiation or modification of ARV treatment.

Monitor ALT,AST, and total bilirubin, basic chemistry including serum sodium, potassium, bicarbonate, chloride, BUN, creatinine, and creatinine-based estimated glomerular filtration rate.


  • Rash

  • Diarrhea

  • Peripheral neuropathy


  • Myocardial infarction

  • Erythema multiforme

  • Stevens-Johnson syndrome

  • Toxic epidermal necrolysis

  • Hepatitis

  • Liver failure

  • Drug reaction with eosinophilia and systemic symptoms

  • Immune reconstitution syndrome

  • Rhabdomyolysis

Multiple drug-drug interactions


  • Maroviroc

  • Dasabuvir

Antimicrobial class: Antiretroviral, Non-nucleoside reverse transcriptase inhibitor

Pregnancy category: B

Average serum half life: 9.05 - 41 hours

Urine penetration: Therapeutic

CSF penetration: Therapeutic

Precautions: Immune reconstitution syndrome has been reported with combination ARV therapy; patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections.

Discontinue immediately and monitoring recommended if hypersensitivity reactions or severe rash occurs.

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.